Autres langues Zeria Pharmaceutical Co., Ltd.

Actions

4559

JP3428850006

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 14/05/2024			Varia. 5j.	Varia. 1 janv.
2 045 ^JPY	+0,29%		-2,39%	+1,39%

09/05	Zeria Pharmaceutical Co. annonce un dividende de fin d'année pour l'exercice se clôturant le 31 mars 2024, payable le 28 juin 2024	CI
09/05	Zeria Pharmaceutical Co. présente ses prévisions de résultats consolidés pour les six premiers mois et l'année entière se terminant le 31 mars 2025	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Zeria Pharmaceutical Co., Ltd. Announces Year End Dividend for the Full Year Ending March 31, 2024, Payable on June 28, 2024	09/05
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2025	09/05
Zeria Pharmaceutical Co., Ltd. Provides Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2025	09/05
Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints	23/04
Zeria Pharmaceutical's Profit Up 41% in Fiscal Q1-Q3	16/02
Japanese Shares End Firmer on Friday on BoJ Policy Outlook	17/11
Zeria Pharmaceutical Books Higher Fiscal H1 Attributable Profit on Loss Provision Reversal	17/11
Zeria Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter of Fiscal Year Ending March 31, 2024, Payable on December 1, 2023	16/11
Zeria Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	16/11
Zeria Pharmaceutical’s Attributable Profit Up 12.1% in Fiscal Q1 on Absence of Forex Losses	23/08/23
Zeria Pharmaceutical Co., Ltd. Provides Dividend Forecast for the Fiscal Year Ending March 31, 2024	22/08/23
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for the Six Months of 2024 and the Fiscal Year Ending March 31, 2024	22/08/23
Zeria Pharmaceutical Co., Ltd. Provides Dividend Forecast for the Second Quarter of 2024	22/08/23
Zeria Pharmaceutical : 69th Business Report (From April 1, 2022 to March 31, 2023.)	25/07/23
Zeria Pharmaceutical : Notice of the 69th Ordinary Stockholders' General Assembly	26/05/23
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.	16/05/23
Zeria Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 11, 2022, has closed with 263,900 shares, representing 0.6% for ¥545.29 million.	12/05/23
Zeria Pharmaceutical Co., Ltd. Provides Year End Dividend Guidance for the Full Year Ending March 31, 2024	11/05/23
Zeria Pharmaceutical Co., Ltd. Announces Year End Dividend for the Full Year Ending March 31, 2023, Payable on June 30, 2023; Provides Second Quarter Dividend Guidance for the Full Year Ending March 31, 2024	11/05/23
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2024	11/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zeria Pharmaceutical Co., Ltd.

Actions

4559

JP3428850006

Autres langues

Filtres